---
$id: https://graph.org.ai/products/commodity/51171944
$type: Product
source: UNSPSC
code: "51171944"
title: "Irsogladine"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Irsogladine

**UNSPSC Code**: 51171944
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-ulcer agent with the molecular formula C9H7Cl2N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QBX79NZC1D, chemically known as 1,3,5-triazine-2,4-diamine, 6-(2,5-dichlorophenyl)- but generally known as irsogladine, which bears US NIH Compound Identifier 3752. European Medicines Agency schedules Irsogladine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08299MIG. The term IRSOGLADINE is an International Non-Proprietary Name. IRSOGLADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule irsogladine under HS 29336980 and SITC 51576. As of Q4 2014, IRSOGLADINE remains the US FDA Preferred Term for this commodity. Irsogladine bears US NLM identifiers UMLS ID C0063879 and NCI Concept Code C65964. SMILES: CLC1C(C2NC(NC(N2)N)N)CC(CL)CC1.

